News Search Results
May 18, 2026, 09:00 ET Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions
May 18, 2026, 08:00 ET Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026
company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases
More news about: Astellas Pharma Inc.
May 15, 2026, 10:00 ET SightMD Pennsylvania Welcomes Katlyn Kozell, OD to Wyomissing and Pottsville Locations
www.sightmd.com or call 800.823.5530.SightMD Pennsylvania is actively seeking ophthalmology professionals who are interested in joining its outstanding team. If you are an ophthalmology practice owner interested in merging or selling your practice, please contact the Chief Medical Officer,
More news about: SightMD
May 15, 2026, 09:00 ET Guideway Care Appoints National Clinical and Health System Leaders to Patient Activation Clinical Advisory Board
Chief Executive Officer of the American Board of Ophthalmology; former Chair of Mayo Clinic's Department of Ophthalmology; former member of the Mayo Clinic Board of Governors; CEO Emeritus of Mayo Clinic in Florida; former Editor-in-Chief of Ophthalmology; former President of the American Ophthalmological
More news about: Guideway Care
May 15, 2026, 07:36 ET Keenova Announces Newly Updated Peyronie's Disease Study Results at American Urology Association Meeting
diversified brands portfolio, which is focused across a wide range of specialty therapeutic areas of significant unmet need. These include rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology, and neonatal respiratory critical care.Headquartered in Dublin, Ireland, Keenova
More news about: Keenova Therapeutics
May 14, 2026, 02:00 ET World First: Babies Screened for Blindness Using Artificial Intelligence
Chuluunbat, head of pediatric ophthalmology at NCMCH, "We believe this reflects the combined efforts of our dedicated national and international team, which will address the issue of retinopathy of prematurity in Mongolia and contribute to the scientific field of pediatric ophthalmology."Otgonchimeg once
More news about: Orbis International
May 13, 2026, 10:45 ET Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions
May 13, 2026, 10:37 ET Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions
May 13, 2026, 09:00 ET ZEISS expands ophthalmic surgical workflows in Mexico with COFEPRIS approval for ARTEVO 850 and MICOR 700
XXXVIII Mexican Congress of Ophthalmology (SMO) in Monterrey, Mexico, from May 30 – June 3, 2026.
More news about: Carl Zeiss Meditec AG
May 13, 2026, 09:00 ET ZEISS expands ophthalmic surgical workflows in Mexico with COFEPRIS approval for ARTEVO 850 and MICOR 700
XXXVIII Mexican Congress of Ophthalmology (SMO) in Monterrey, Mexico, from May 30 – June 3, 2026.
More news about: Carl Zeiss Meditec AG
May 13, 2026, 08:30 ET InMode to Present at Upcoming Investor Conferences and Events
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.Forward-Looking
More news about: InMode Ltd.
May 13, 2026, 08:00 ET Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
Executive Vice President, Global Head of Specialty Medicine. During his tenure, he provided leadership across multiple therapeutic areas, including ophthalmology, neurology, hematology, and cardiology, and oversaw the global launch of EYLEA®. Mr. Dable currently serves as an advisor at RA Capital Management,
More news about: Tyra Biosciences
May 12, 2026, 20:00 ET Innovent to Present Multiple Clinical and Preclinical Results of Mazdutide and Next-Generation Obesity & Metabolic Pipeline at the 2026 ADA Scientific Sessions
that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that it will present multiple clinical and preclinical data from mazdutide and its next‑generation obesity and
More news about: Innovent Biologics
May 12, 2026, 10:38 ET Medical Device Contract Manufacturing Market 2026-2031: To Reach USD 171.03 Billion by 2031 As Precision Manufacturing Technologies Gain Traction, Says Mordor Intelligence
DevicesDrug-Delivery DevicesSyringesPen InjectorsOthersEndoscopy DevicesOphthalmology DevicesOrthopedic DevicesDental DevicesOther DevicesBy Service Device Development
More news about: Mordor Intelligence Private Limited
May 12, 2026, 09:00 ET IZERVAY® (avacincaptad pegol intravitreal solution) Demonstrated Increased Probability of Maintaining Driving Eligibility in Geographic Atrophy Patients
geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The findings, presented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Denver, Colorado, suggested treatment benefits of IZERVAY increased over time.
More news about: Astellas Pharma Inc.
May 12, 2026, 06:30 ET Keenova Reports First Quarter 2026 Financial Results
diversified brands portfolio, which is focused across a wide range of specialty therapeutic areas of significant unmet need. These include rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology, and neonatal respiratory critical care.Headquartered in Dublin, Ireland, Keenova
More news about: Keenova Therapeutics
May 11, 2026, 08:00 ET AI4Eyes Graduates from Creative Destruction Lab AI & Wins RBCx Innovation Prize
milestone marks an important step forward for the company as it continues developing artificial intelligence solutions to support the future of Ophthalmology and eye care.Throughout the CDL program, AI4Eyes was challenged to sharpen its strategy, refine its vision, and focus on the goals that will
More news about: AI4Eyes Medical Technologies Inc.
May 10, 2026, 20:00 ET Innovent Announces IBI363 (PD-1/IL-2α-bias Bispecific Fusion Protein) Received Third NMPA Breakthrough Therapy Designation for MSS/pMMR Metastatic Colorectal Cancer
that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other major diseases, announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted
More news about: Innovent Biologics
May 08, 2026, 13:48 ET Basata Raises $21M Series A to Rebuild the $1T Operational Layer of American Healthcare
100,000 in the past month, and works with providers some of the largest specialty groups in the country across cardiology, urology, gastroenterology, ophthalmology, and growing.Practices using Basata process 100% of incoming referrals the same day, unlock 50% more administrative labor capacity, and reduce
More news about: Basata
May 07, 2026, 10:08 ET Light Field Technology Market to Reach US$ 440.3 Million by 2032 Expands Amid Rising Demand for Immersive Imaging and AI-Driven Visualization - Persistence Market Research
significant advantages over traditional imaging methods.The healthcare sector is also embracing AI-enhanced light field imaging for radiology, ophthalmology, and surgical planning. According to the Medscape & HIMSS AI Adoption Report 2024, 86% of health systems already use AI technologies, with 60%
More news about: Persistence Market Research Pvt. Ltd.
May 07, 2026, 08:00 ET Artera Announces AI Services Model for Specialty Care, FQHCs and More
diverse clinical areas, including: Behavioral Health, Cardiology, Dermatology, Family Medicine & Primary Care, Gastroenterology, Oncology, Ophthalmology & Optometry, Orthopedics, Otolaryngology (ENT), Pediatrics, Urology, Women's Health and others.Federally Qualified
More news about: Artera
May 07, 2026, 07:05 ET REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting
activity compared to AAV8Poster: 1031Presenter: Brendan Lilley, Ph.D., Director of Ophthalmology Research, REGENXBIOLocation: MCEC Exhibit and Poster Hall (Halls B2-C, Exhibit level)Date/Time: Tuesday,
More news about: REGENXBIO Inc.
May 07, 2026, 07:00 ET Nitra Launches "Future of Care Initiative," Commits $20 Billion in Financing for Independent Medical Practices Across America
completed his training at the Massachusetts Eye and Ear Infirmary at Harvard Medical School, where he served as Chief Resident and Associate Chief of Ophthalmology.Dr. Lester Zuckerman is the co-founder and former Chief Medical Officer of National Spine & Pain Centers, one of the country's
More news about: Nitra
May 07, 2026, 06:59 ET Viatris Reports First-Quarter 2026 Financial Results
Cataract and Refractive Surgery Annual Meeting in Washington, D.C., April 10-13, 2026. The presentations included data across various areas of ophthalmology, including full results from VEGA-3, a Phase 3 study evaluating MR-141 (phentolamine ophthalmic solution 0.75%) for presbyopia.In March
More news about: Viatris Inc.
May 06, 2026, 09:00 ET Graphy Cements Role as 'Digital Orthodontics Standard' at AAO 2026, Accelerating Global Expansion
prominent New York-based healthcare management company. Operating on a model similar to a Dental Service Organization (DSO) but specialized in ophthalmology and optometry clinics, Eye&I brings extensive expertise in scaling specialized clinical services.Through this partnership, the two companies
More news about: Graphy Inc.